Prognostic significance of adjuvant chemotherapy in stage I-II endometrial carcinoma patients who underwent lymphadenectomy.

Jiro SuzukiHiroshi TanabeHirofumi MichimaeYuki KoikeMisato KamiiKazuaki TakahashiMasataka TakenakaMotoaki SaitoHirokuni TakanoKyosuke YamadaAikou Okamoto

Published in: International journal of clinical oncology (2024)

The findings suggest that postoperative adjuvant chemotherapy does not significantly contribute to the improvement of recurrence or prognosis in patients with stage I-II endometrial carcinoma who are categorized outside the low-risk group and have no lymph-node metastasis.

Keyphrases

lymph node metastasis
end stage renal disease
squamous cell carcinoma
ejection fraction
papillary thyroid
chronic kidney disease
newly diagnosed
lymph node
prognostic factors
peritoneal dialysis
endometrial cancer
early stage
patient reported outcomes